Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapy.
Am J Transplant
; 23(1): 84-92, 2023 01.
Article
en En
| MEDLINE
| ID: mdl-36695625
Palabras clave
cellular transplantation (nonislet); immunosuppressant-fusion proteins and monoclonal antibodies: belatacept; immunosuppressant-polyclonal preparations: rabbit antithymocyte globulin; immunosuppression/immune modulation; immunosuppressive regimens-induction; kidney transplantation/nephrology; tolerance; tolerance: clinical; translational research/science
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Trasplante de Riñón
/
Suero Antilinfocítico
Tipo de estudio:
Clinical_trials
Límite:
Humans
Idioma:
En
Revista:
Am J Transplant
Asunto de la revista:
TRANSPLANTE
Año:
2023
Tipo del documento:
Article
País de afiliación:
Austria